Clinical Trial Update: Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of high-dose rifampicin in TB-HIV co-infected patients on efavirenz- or dolutegravir-based ART completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Makerere University | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED